⌘K

Login Start Free

Home/Filings/4/0001493152-20-024516

4//SEC Filing

Kruger Kurt H 4

Accession 0001493152-20-024516

CIK 0001460702other

View on SEC.gov Company Profile

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 6:05 AM ET

Size

4.6 KB

Accession

0001493152-20-024516

Insider Transaction Report

Form 4

Period: 2020-12-29

Qualigen Therapeutics, Inc.QLGN

Director

Transactions

Purchase
Common Stock
2020-12-29$2.94/sh+4,000$11,740→ 10,000 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Qualigen Therapeutics, Inc.

CIK 0001460702

Entity typeother

Related Parties

1

filerCIK 0001375881

Filing Metadata

Form type: 4
Filed: Dec 29, 7:00 PM ET
Accepted: Dec 30, 6:05 AM ET
Size: 4.6 KB

View on SEC.gov